Sonora Investment Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,014
| Closed | -$1K | – | 1823 |
|
|
2019
Q4 | $1K | Hold |
1,014
| – | – | ﹤0.01% | 1652 |
|
|
2019
Q3 | $1K | Hold |
1,014
| – | – | ﹤0.01% | 1643 |
|
|
2019
Q2 | $1K | Hold |
1,014
| – | – | ﹤0.01% | 1653 |
|
|
2019
Q1 | $0 | Hold |
1,014
| – | – | ﹤0.01% | 1571 |
|
|
2018
Q4 | $0 | Hold |
1,014
| – | – | ﹤0.01% | 1352 |
|
|
2018
Q3 | $1K | Hold |
1,014
| – | – | ﹤0.01% | 1191 |
|
|
2018
Q2 | $1K | Hold |
1,014
| – | – | ﹤0.01% | 1156 |
|
|
2018
Q1 | $429 | Hold |
1,014
| – | – | ﹤0.01% | 1149 |
|
|
2017
Q4 | $385 | Hold |
1,014
| – | – | ﹤0.01% | 1163 |
|
|
2017
Q3 | $365 | Hold |
1,014
| – | – | ﹤0.01% | 1121 |
|
|
2017
Q2 | $385 | Hold |
1,014
| – | – | ﹤0.01% | 957 |
|
|
2017
Q1 | $456 | Hold |
1,014
| – | – | ﹤0.01% | 905 |
|
|
2016
Q4 | $385 | Sell |
1,014
-234
| -19% | -$79 | ﹤0.01% | 825 |
|
|
2016
Q3 | $337 | Hold |
1,248
| – | – | ﹤0.01% | 807 |
|
|
2016
Q2 | $300 | Sell |
1,248
-1,000
| -44% | -$172 | ﹤0.01% | 833 |
|
|
2016
Q1 | $292 | Buy |
2,248
+614
| +38% | +$67 | ﹤0.01% | 924 |
|
|
2015
Q4 | $0 | Sell |
1,634
-1,394
| -46% | -$197 | ﹤0.01% | 1345 |
|
|
2015
Q3 | $1K | Buy |
+3,028
| New | +$1.03K | ﹤0.01% | 1077 |
|
Sonora Investment Management's GCVRZ Position: Q1 2020 in Review
Sonora Investment Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 1,014 shares — an estimated $1K sold.
Sonora Investment Management first reported a position in GCVRZ in Q3 2015 and held it in 18 quarters. The position peaked at $1K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Sonora Investment Management reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Sonora Investment Management sold 1,014 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $1K.
- Sonora Investment Management first reported a position in Sanofi Contingent Value Rights in Q3 2015 and held it in 18 quarters.
- Sonora Investment Management's Sanofi Contingent Value Rights position peaked at $1K in Q4 2019.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Sonora Investment Management's 13F filing for Q1 2020, filed 29 Apr 2020.